Distribution rights in the United States of uridine triacetate drug. The drug is used for treating patients at risk of serious toxicity following an overdose of 5-flourouracil.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Wellstat Therapeutics Corporation (rights to uridine triacetate)‘s full profile, request access.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Wellstat Therapeutics Corporation (rights to uridine triacetate)‘s full profile, request access.
Request a free trial